A small study suggests Mavenclad’s effectiveness in MS may be linked to how regulatory T-cells respond to treatment.

Teva Canada and Novartis Canada are collaborating to ensure continued access to Mayzent for people with active SPMS in Canada ...

BTK inhibitors such as tolebrutinib or evobrutinib work about as well as Aubagio at preventing relapses in MS, a review of ...

Signs of multiple sclerosis may surface years before diagnosis, as patients use healthcare more often for early symptoms.

A higher adherence to a Mediterranean diet is linked to a lower risk of developing MS, particularly in nonsmokers and people ...

Researchers have found that new myelin-making cells are constantly being made in the brain and spinal cord, even in the ...

Difficulty walking with MS is not just about physical limitations, but also emotions, stigma, and how others respond, a ...

A brief, four-session stress management program helped ease symptoms of depression and anxiety and reduced stress in people ...

Cognitive impairment is more common and severe in older adults with MS than in younger patients, but this is driven by ...

Columnist Ben Hofmeister likens the three battlefield ways to degrade an adversary's abilities to the disruptions caused by ...

A small study found MS patients reported improved quality of life and reduced depression after Ocrelizumab biosimilar treatment ...

Dancing the night away with an old friend reminded columnist Susan Payrovi, MD, how much she benefits from seeking joy and connection.